Inspirion Wealth Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
Other funds holding VIRX
XT
UCFA
WA
BBA
RM
Inspirion Wealth Advisors's VIRX Position: Q1 2025 in Review
Inspirion Wealth Advisors sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q1 2025, closing a stake of 25,000 shares — an estimated $5.28K sold.
Inspirion Wealth Advisors first reported a position in VIRX in Q4 2023 and held it in 5 quarters. The position peaked at $15.3K in Q1 2024. 7 funds tracked by Wall St. Rank hold VIRX as of Q1 2025.
- Inspirion Wealth Advisors reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Inspirion Wealth Advisors sold 25,000 Viracta Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $5.28K.
- Inspirion Wealth Advisors first reported a position in Viracta Therapeutics, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
- Inspirion Wealth Advisors's Viracta Therapeutics, Inc. Common Stock position peaked at $15.3K in Q1 2024.
- 7 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q1 2025.
Based on Inspirion Wealth Advisors's 13F filing for Q1 2025, filed 9 Apr 2025.